Selected Grants
Convener and Organizer of Activities and Engagements Related to Processes, Surveillance, and Policy Development of Medical Products for Ongoing Public Health Activities, U01 Clinical Trial Not Allowed
ResearchPrincipal Investigator · Awarded by Food and Drug Administration · 2024 - 2029CF Cooperative Agreement to Support Regulatory Research Related to the 2022 Prescription Drug User Fee Act and Biosimilar User Fee Act (U19)
ResearchPrincipal Investigator · Awarded by Food and Drug Administration · 2018 - 2028Advancing Evidence-Based U.S. Health Policy for Global Impact
ResearchPrincipal Investigator · Awarded by Bill and Melinda Gates Foundation · 2026 - 2028Accelerating Value-Based Care Impact at the State and National Level
ResearchPrincipal Investigator · Awarded by Gary and Mary West Health Policy Center · 2023 - 2027Accelerating Value-Based Care Impact at the State and National Level
ResearchPrincipal Investigator · Awarded by Gary and Mary West Health Institute · 2023 - 2027Biomarkers Qualification
ResearchPrincipal Investigator · Awarded by Biotechnology Innovation Organization · 2025 - 2027Implementing the Inflation Reduction Act: Proposal to Address Key Issues for Advancing Pharmaceutical Innovation, Access, Affordability, and Impact
ResearchPrincipal Investigator · Awarded by National Pharmaceutical Council · 2024 - 2026Highlander Health Institute: Source Data Project
ResearchPrincipal Investigator · Awarded by Highlander Health Institute · 2024 - 2026Strategic Management of the Health Care Payment Learning and Action Network 3.0 (LAN 3.0)
ResearchPrincipal Investigator · Awarded by Deloitte Consulting LLP · 2024 - 2026Medicaid Best Price and the Medicaid Drug Rebate Program in the Context of Cell and Gene Therapies
ResearchPrincipal Investigator · Awarded by Arnold Ventures · 2025 - 2026Pathways and Policies to Support Drug Repurposing
ResearchPrincipal Investigator · Awarded by Arnold Ventures · 2024 - 2025Next-Gen COVID-19 Detection and Response in the United States
ResearchProject Lead · Awarded by Bill and Melinda Gates Foundation · 2022 - 2025Convener and organizer of activities and engagements focused on the development of medical products and related processes, surveillance, and policies relevant to ongoing public health activities
ResearchPrincipal Investigator · Awarded by Food and Drug Administration · 2019 - 2024Novel Antibiotics Webinar Series
ResearchPrincipal Investigator · Awarded by AMR Action Fund · 2023 - 2024A Progress-Based Assessment of Critical Clinical Trial Design Dimensions Supporting Representative Enrollment
ResearchPrincipal Investigator · Awarded by Robert Wood Johnson Foundation · 2022 - 2024The Next Phase of Antimicrobial Resistance Payment Policy
ResearchPrincipal Investigator · Awarded by Wellcome Trust · 2022 - 2023Understanding Bias in AI-enabled Health Care Products
ResearchAdvisor · Awarded by Pew Charitable Trusts · 2021 - 2022COVID-19 Real World Evidence for Monoclonal Antibodies
ResearchAdvisor · Awarded by Mitre Corporation · 2021 - 2022Overcoming the Impediments to Biosimilar Adoption in the United States¿What Can Be Learned from the Success of Other Countries?
ResearchProject Manager · Awarded by Commonwealth Fund · 2020 - 2021AHA project
ResearchProject Director · Awarded by American Heart Association · 2018 - 2019Special Analysis of Part D Drug Prices
ResearchPrincipal Investigator · Awarded by Mitre Corporation · 2018 - 2018External Relationships
- National Science Foundation Engineering Research Center for Cell Manufacturing Technologies (as part of my duties at Duke)
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.